IDENTIV, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.12 USD | 0.00% |
|
+0.99% | -37.86% |
| Apr. 26 | Identiv Initiates 'Multiple' Legal Proceedings Against Tageos | MT |
| Apr. 03 | Identiv to Sell Certain Assets to Vitaprotech for $145 Million in Cash; Shares Fall | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 95.27 | 153.2 | 624.9 | 163 | 191 | 119.5 | - | - |
| Enterprise Value (EV) 1 | 101.7 | 153.2 | 624.9 | 163 | 191 | 119.5 | 119.5 | 119.5 |
| P/E ratio | -43.4 x | -25 x | 1,407 x | -103 x | -28.4 x | -22.9 x | -66.8 x | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 1.14 x | 1.76 x | 6.02 x | 1.44 x | 1.64 x | 1.01 x | 0.93 x | 0.93 x |
| EV / Revenue | 1.14 x | 1.76 x | 6.02 x | 1.44 x | 1.64 x | 1.01 x | 0.93 x | 0.93 x |
| EV / EBITDA | 14 x | 35 x | 154 x | 30.4 x | 68.3 x | 26.4 x | 13.4 x | 7.24 x |
| EV / FCF | 690,380,388 x | - | - | - | - | - | - | - |
| FCF Yield | 0% | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 16,892 | 18,020 | 22,207 | 22,513 | 23,174 | 23,331 | - | - |
| Reference price 2 | 5.640 | 8.500 | 28.14 | 7.240 | 8.240 | 5.120 | 5.120 | 5.120 |
| Announcement Date | 3/12/20 | 3/4/21 | 3/2/22 | 3/2/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 83.76 | 86.92 | 103.8 | 112.9 | 116.4 | 117.8 | 128.4 | 127.9 |
| EBITDA 1 | 6.79 | 4.382 | 4.047 | 5.37 | 2.797 | 4.528 | 8.9 | 16.5 |
| EBIT 1 | -0.109 | -3.448 | -1.347 | -0.333 | -5.055 | -4.472 | -1.3 | - |
| Operating Margin | -0.13% | -3.97% | -1.3% | -0.29% | -4.34% | -3.8% | -1.01% | - |
| Earnings before Tax (EBT) 1 | -0.825 | -5.032 | 1.648 | -0.291 | -5.325 | -4.872 | -1.58 | - |
| Net income 1 | -2.193 | -6.199 | 0.472 | -1.598 | -6.755 | -2.516 | -0.255 | - |
| Net margin | -2.62% | -7.13% | 0.45% | -1.42% | -5.8% | -2.14% | -0.2% | - |
| EPS 2 | -0.1300 | -0.3400 | 0.0200 | -0.0700 | -0.2900 | -0.2233 | -0.0767 | - |
| Free Cash Flow | 0.138 | - | - | - | - | - | - | - |
| FCF margin | 0.16% | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | 2.03% | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/4/21 | 3/2/22 | 3/2/23 | 3/12/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 29.1 | 28.52 | 25.06 | 27.86 | 31 | 29 | 26 | 29.56 | 31.85 | 28.98 | 23 | 27.27 | 33.43 | 33.6 | 27.6 |
| EBITDA 1 | 3.233 | -0.732 | 0.243 | 1.356 | 2.038 | 1.733 | -0.928 | 0.69 | 2.166 | 0.869 | -1.069 | 0.282 | 2.363 | 2.316 | - |
| EBIT 1 | 2.06 | -1.878 | -1.021 | -0.261 | 0.549 | 0.4 | -2.732 | -1.03 | 0.341 | -1.634 | -3.278 | -1.731 | 0.066 | 0.472 | - |
| Operating Margin | 7.08% | -6.59% | -4.07% | -0.94% | 1.77% | 1.38% | -10.51% | -3.49% | 1.07% | -5.64% | -14.25% | -6.35% | 0.2% | 1.4% | - |
| Earnings before Tax (EBT) 1 | 2.561 | -1.987 | -1.003 | -0.197 | 0.507 | 0.402 | -2.693 | -1.129 | -0.002 | -1.501 | -3.378 | -1.831 | -0.034 | 0.372 | - |
| Net income 1 | 2.251 | -2.21 | -1.297 | -0.551 | 0.215 | 0.035 | -3.032 | -1.459 | -0.341 | -1.923 | -3.094 | -1.498 | 0.583 | 0.536 | - |
| Net margin | 7.74% | -7.75% | -5.18% | -1.98% | 0.69% | 0.12% | -11.66% | -4.94% | -1.07% | -6.63% | -13.45% | -5.49% | 1.74% | 1.6% | - |
| EPS 2 | 0.0900 | -0.1000 | -0.0600 | -0.0200 | 0.0100 | - | -0.1300 | -0.0600 | -0.0100 | -0.0800 | -0.1533 | -0.0833 | 0.006670 | -0.003330 | -0.1100 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/2/21 | 3/2/22 | 5/4/22 | 8/3/22 | 11/2/22 | 3/2/23 | 5/4/23 | 8/3/23 | 11/7/23 | 3/12/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | 6.48 | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.9539 x | - | - | - | - | - | - | - |
| Free Cash Flow | 0.14 | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex | 0.29 | - | - | - | - | - | - | - |
| Capex / Sales | 0.35% | - | - | - | - | - | - | - |
| Announcement Date | 3/12/20 | 3/4/21 | 3/2/22 | 3/2/23 | 3/12/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.12
USD
Average target price
10
USD
Spread / Average Target
+95.31%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -37.86% | 119M | |
| +12.06% | 101B | |
| -0.62% | 30.04B | |
| +12.05% | 21.97B | |
| -16.05% | 17.86B | |
| -6.34% | 17.46B | |
| +8.74% | 15.04B | |
| -4.89% | 12.09B | |
| -2.85% | 10.26B | |
| -8.86% | 8.8B |
- Stock Market
- Equities
- INVE Stock
- Financials Identiv, Inc.
